Text message reminder aims to boost cancer screening rates
NCT ID NCT07628998
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether sending a single SMS reminder to people who haven't completed a colorectal cancer screening test can increase participation. Over 10,000 adults aged 50-69 in Spain will be randomly assigned to receive either the SMS or standard postal reminders. The goal is to see if a simple text can help meet the recommended 65% screening target.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SMS text message reminder
What this could lead to
If it works, this could show that a simple text message can significantly increase colorectal cancer screening rates, helping catch cancer earlier.
What could go wrong
This is a behavioral study, not a medical treatment. The effect may be small or not apply to other regions. It only measures participation, not cancer outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Unitat de Cribratge de Cáncer, Consorci Corporació Sanitaria Parc Taulí
RECRUITINGSabadell, Catalonia, 08208, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact